Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
8301por Lin, Yiqi, Li, Binyin, Tang, Huidong, Xu, Qun, Wu, Yuncheng, Cheng, Qi, Li, Chunbo, Xiao, Shifu, Shen, Lu, Tang, Weiguo, Yu, Hui, He, Naying, Lin, Huawei, Yan, Fuhua, Cao, Wenwei, Yang, Shilin, Liu, Ye, Zhao, Wei, Lu, Dong, Jiao, Bin, Xiao, Xuewen, Zhou, Lin, Chen, Shengdi“…With 80–90% statistical power and 12% as the overall probability of conversion within the study period, 600–800 patients are finally required in the study. The first patent has been recruited in April 2017. DISCUSSION: Previous studies suggested the benefit of cognitive training for MCI, but neither long-time nor Chinese culture were investigated. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8302por Eschbach, Matthew, Sindberg, Gregory M, Godek, Marisha L, Nagelschmidt, Matthew, Paquette, Nicholas, Wegener, Michael, Alberino, James, Mayotte, Jane, Vasanji, Amit, Miesse, Andrew M“…Stomachs were then imaged using micro-computed tomography and subsequent analysis was utilized to quantify fluid volume and patent vasculature proximity to staples within the staple line region for each group. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8303“…Clinicopathologic features, overall survival (OS) and recurrence-free survival (RFS) of ccRCC patents were all collected. IDH1 expression level was assessed by immunohistochemistry and its association with clinicopathologic features and outcomes were also evaluated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8304por Sutanto, Inge, Kosasih, Ayleen, Elyazar, Iqbal R F, Simanjuntak, Deddy R, Larasati, Tri A, Dahlan, M Sopiyudin, Wahid, Isra, Mueller, Ivo, Koepfli, Cristian, Kusriastuti, Rita, Surya, Asik, Laihad, Ferdinand J, Hawley, William A, Collins, Frank H, Baird, J Kevin, Lobo, Neil F“…RESULTS: The risk ratios for incidence density of microscopically patent malaria in MST3 or MST2 relative to that in MST0 clusters were 1.00 (95% confidence interval [CI], .53–1.91) and 1.22 (95% CI, .42–3.55), respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8305“…The left peroneal artery and posterior tibial artery remained patent. INTERVENTION: Total knee arthroplasty using navigation without the use of tourniquet. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8306por Cheru, Lediya T, Park, Elli A, Saylor, Charles F, Burdo, Tricia H, Fitch, Kathleen V, Looby, Sara, Weiner, Jeffrey, Robinson, Jake A, Hubbard, Jane, Torriani, Martin, Lo, Janet“…We hypothesized that I-FABP would be increased in chronically HIV-infected patents more than elite controllers and would relate to specific nutrient intake and body composition. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8307“…Purely surgical ligation of patent ductus arteriosus was excluded from this study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8308por Chitnis, Nakul, Pemberton-Ross, Peter, Yukich, Josh, Hamainza, Busiku, Miller, John, Reiker, Theresa, Eisele, Thomas P., Smith, Thomas A.“…Prevalence survey data from recent studies in Zambia were used to capture the effects of spatial clustering of patent infections. RESULTS: RCD proved most effective at low prevalence. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8309por Malgwi, Samson Anjikwi, Zango, Mohammed Kyari, Mbaya, Albert Wulari, Dennis, Gamgong, Kyari, Falmata, Sanda, Kyari Abba, Balami, Stephen Bitrus, Bwala, Abwari David“…RESULTS: Infected Groups (A, B, C, E, and F) showed a pre-patent period 2 days post infection (P.I) with mean parasitic counts of 3.93 ± 2.38, 2.46 ± 2.20, 0.67 ± 0.77, 4.60 ± 4.45, and 1.53 ± 1.44, respectively, which continued unabated in groups treated with the extract.The pack cell volume did not decline significantly in the in Groups A and B. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8310“…MAIN OUTCOME MEASURES: In each practice the following were measured: the timing of the largest changes, steepness of the change slope (change in proportion per month), and magnitude of the change for two example time series (expiry of the Cerazette patent in 2012, leading to cheaper generic desogestrel alternatives becoming available; and a change in antibiotic prescribing guidelines after 2014, favouring nitrofurantoin over trimethoprim for uncomplicated urinary tract infection (UTI)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8311por Adams, Mark, Bassler, Dirk, Darlow, Brian A, Lui, Kei, Reichman, Brian, Hakansson, Stellan, Norman, Mikael, Lee, Shoo K, Helenius, Kjell K, Lehtonen, Liisa, San Feliciano, Laura, Vento, Maximo, Moroni, Marco, Beltempo, Marc, Yang, Junmin, Shah, Prakesh S“…EXPOSURES: NEC prevention practices (probiotics, feeding, donor milk) using responses of an on-line pre-piloted questionnaire containing 10 questions and factors associated with NEC in literature (antenatal steroids, c-section, indomethacin treated patent ductus arteriosus and sepsis) using cohort data. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8312“…METHODS: Informed by scientific evidence and the voices of patients, families and healthcare professionals, the Person-Centered Care Certification Programme was developed as a comprehensive measure of PCC (Person-Centered Care Certification is a registered trademark of Planetree Registered in the US Patent and Trademark Office). Ten years after its development, the programme was redesigned to offer a more complete evaluative framework to focus organisations’ PCC efforts and better understand their impact. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8313“…INTRODUCTION: The optimal management of patent ductus arteriosus (PDA) remains contentious. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8314por Cui, Xin, Liang, Long, Wang, Lianxin, Wang, Zhifei, Li, Yuanyuan, Gao, Yang, Zhang, Cheng, Sun, Menghua, Wang, Shiheng, Liu, Jiani, Zhang, Yue, wang, Zhibo, Wei, Xu, Xie, Yanming“…As a kind of Chinese patent medicine, Shujinjianyao pill (SJJYP) has a great curative effect on low back pain. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8315por Ma, Alan, Gurnasinghani, Sunita, Kirk, Edwin P., McClenaghan, Conor, Singh, Gautam K., Grange, Dorothy K., Pandit, Chetan, Zhu, Yung, Roscioli, Tony, Elakis, George, Buckley, Michael, Mehta, Bhavesh, Roberts, Philip, Mervis, Jonathan, Biggin, Andrew, Nichols, Colin G.“…Initial echocardiogram revealed a large patent ductus arteriosus (PDA), and high pulmonary pressures with enlarged right ventricle. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8316por Gao, Jiaming, Wang, Taiyi, Yao, Xi, Xie, Weiwei, Shi, Xianru, He, Shuang, Zhao, Tao, Wang, Chunhua, Zhu, Yan“…BACKGROUND: Shenxian-Shengmai (SXSM) Oral Liquid is a CFDA-approved patent Chinese Herbal medicine, which has been clinically used for the treatment of bradycardia. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8317por Yao, Shu-Hui, Tsai, Hsiang-Te, Lin, Wen-Lin, Chen, Yu-Chieh, Chou, Chiahung, Lin, Hsiang-Wen“…This study aimed to compare the concentrations of digoxin predicted by traditional regression modeling and artificial neural network (ANN) modeling for newborn infants given digoxin for clinically significant patent ductus arteriosus (PDA). METHODS: A retrospective chart review was conducted to obtain data on digoxin use for clinically significant PDA in a neonatal intensive care unit. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8318por Nicholson, George T., Glatz, Andrew C., Qureshi, Athar M., Petit, Christopher J., Meadows, Jeffery J., McCracken, Courtney, Kelleman, Michael, Bauser‐Heaton, Holly, Gartenberg, Ari J., Ligon, R. Allen, Aggarwal, Varun, Kwakye, Derek B., Goldstein, Bryan H.“…METHODS AND RESULTS: This was a retrospective multicenter study of infants with ductal‐dependent pulmonary blood flow palliated with patent ductus arteriosus (PDA) stent or Blalock‐Taussig shunt (BTS) from 2008 to 2015. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8319por Ichihashi, Shigeo, Takahara, Mitsuyoshi, Fujimura, Naoki, Nagatomi, Satoru, Iwakoshi, Shinichi, Bolstad, Francesco, Kichikawa, Kimihiko“…METHOD AND ANALYSIS: This multicentre, randomised controlled trial will recruit 200 patients who have fusiform AAA ≥50 mm/rapidly enlarging fusiform AAA, with patent IMA, and randomly allocate them either to a pre-emptive IMA embolisation group or non-embolisation control group in a ratio of 1:1. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8320“…MRI, BAEP, echocardiogram and bronchoscopy revealed that he had persistent falcine sinus with a thin corpus callosum, left auditory pathway disorder, patent foramen ovale (2 mm), and tracheobronchomalacia with the right superior bronchus arising from the lateral posterior wall of the right main bronchus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto